Boundless Bio (BOLD) Payables (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Payables of $5.7 million for Q1 2026, up 15.28% year-over-year from $5.0 million in Q1 2025, and down 15.12% quarter-over-quarter from $6.7 million in Q4 2025.
Boundless Bio (BOLD) Payables (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Payables for 4 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 15.28% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (up 15.28% YoY), while the FY2025 annual figure was $6.7 million, up 25.64% from the prior year.
- Payables declined to $5.7 million in Q1 2026 per BOLD's latest filing, from $6.7 million in the prior quarter.
- Across five years, Payables topped out at $8.2 million in Q1 2024 and bottomed at $1.7 million in Q2 2024.
- Historically, Payables has averaged $5.7 million across 4 years, with a median of $5.8 million in 2025.
- On a YoY basis, Payables climbed as much as 247.27% in 2025 and fell as far as 39.46% in 2025.
- Boundless Bio's Payables stood at $4.3 million in 2023, then gained by 25.5% to $5.4 million in 2024, then climbed by 25.64% to $6.7 million in 2025, then slipped by 15.12% to $5.7 million in 2026.
- Business Quant data shows BOLD's Payables at $5.7 million in Q1 2026, $6.7 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 35.57 Mn |
| 10 | Boundless Bio | 67.01 Mn | 67.01 Mn | - | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.71 Mn |
| Dec 31, 2025 | 6.73 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 7.04 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 4.27 Mn |